The Labs Your Doctor Didn't Run (Pre-Protocol Bloodwork Blueprint)

Your doctor checks total testosterone, tells you it's normal, and sends you home. You still feel exhausted, your libido is flat, and nothing they said actually explains why. That is not a failure of your hormones. That is a failure of the test.

One number without context cannot tell you what is going wrong. To understand why, you need to understand how testosterone actually works in the body, because the system is more layered than most people realize.

The brain starts the whole process. A region called the hypothalamus releases something called GnRH, which is the signal that kicks off the entire hormonal cascade. The pituitary gland receives that signal and responds by releasing two hormones called LH and FSH, which travel through the bloodstream down to the testes. LH is the direct signal that tells the testes to produce testosterone. FSH is the signal that handles sperm production. The testes respond, testosterone enters circulation, and the brain detects that testosterone is present and dials the signal back down. That loop is the whole system.

Now here is why checking only total testosterone tells you almost nothing useful on its own.

Total testosterone measures everything in the blood, but most of that testosterone is not actually available to your cells. A protein called SHBG, which stands for sex hormone binding globulin, acts like a carrier molecule that binds testosterone tightly and keeps it from entering tissues. The testosterone that is not bound to SHBG is what actually gets into cells and does something. That fraction is called free testosterone.

This is why a man with 600 ng/dL total testosterone can have worse symptoms than a man at 400. If the first man has high SHBG, most of his testosterone is locked up and unavailable, and his free testosterone is effectively low. The number looks fine. The biology is not. The harmonized reference range from a study of 9,054 men puts normal total testosterone between 264 and 916 ng/dL, which is an enormous window, and it says nothing at all about what percentage of that testosterone is actually free.

LH and FSH are equally important, and they are almost never tested outside of a fertility workup. If your testosterone is low, LH and FSH tell you where the breakdown is occurring. High LH with low testosterone means the brain is sending the signal loudly and the testes are not responding. That is called primary hypogonadism, and it points to a problem at the testicular level. Low LH with low testosterone means the brain is not sending the signal in the first place. That is secondary hypogonadism, and it points to a problem upstream in the pituitary or hypothalamus. The Endocrine Society guidelines and the American Urological Association both recommend LH testing in any man with low testosterone, because the treatment path changes completely depending on which pattern you find.

Estradiol belongs on this panel too, and it requires measurement with a sensitive assay called LC-MS/MS, which is a method that distinguishes estradiol from other similar molecules that can cause false readings on standard immunoassay tests. Testosterone converts to estradiol through a process called aromatization, and both too much and too little estradiol create symptoms. You cannot manage testosterone without knowing where estradiol is sitting.

The metabolic picture is the second layer that gets missed. A basic metabolic panel includes glucose, but glucose can be completely normal while insulin resistance is already developing underneath the surface. The pancreas compensates for early insulin resistance by producing more insulin, so blood sugar stays normal while insulin climbs. You need fasting insulin to see this, and hemoglobin A1c gives you a 90-day average of blood sugar control rather than a single-day snapshot. Insulin resistance directly suppresses testosterone production and disrupts SHBG, so a hormonal problem and a metabolic problem can look like the same thing without these markers.

Cardiovascular risk markers round out the picture because testosterone therapy affects red blood cell production and lipid metabolism, and you need a baseline before you begin. A standard lipid panel gives you total cholesterol, LDL, HDL, and triglycerides, but it misses something called apolipoprotein B, which counts the actual number of lipoprotein particles carrying cholesterol through the bloodstream. Particle count predicts plaque buildup more accurately than cholesterol weight alone. High-sensitivity C-reactive protein, or hs-CRP, shows whether inflammation is already active in the cardiovascular system, which is a separate risk factor from cholesterol entirely.

Hematocrit, the measure of red blood cells as a percentage of total blood volume, is the safety marker that people on testosterone therapy most commonly overlook. Testosterone stimulates red blood cell production, and if hematocrit rises too high the blood becomes thicker and flow becomes harder. A 2022 study found that men on testosterone therapy with hematocrit at or above 52 percent had a 35 percent higher risk of major cardiovascular events and venous thromboembolism compared to men whose hematocrit stayed lower. That is not a theoretical concern. That is a measurable outcome requiring a baseline to track against.

IGF-1 serves a different purpose. It reflects growth hormone activity in the body. If someone starts a peptide protocol intended to increase growth hormone output, IGF-1 is how you verify that anything is actually happening, and how you monitor for levels rising too high. Without a pre-treatment value you have no reference point.

The thyroid panel matters because thyroid hormone regulates metabolic rate, energy, and the production of SHBG. Hypothyroidism raises SHBG, which lowers free testosterone, so a man can look like he has a testosterone problem when the root is actually a thyroid problem. TSH alone is not enough. Free T3 and free T4 tell you the active hormone levels, not just whether the pituitary is pushing harder to get a response.

The full picture is this: hormones are not isolated numbers but signals in a conversation between the brain, the glands, and the cells, and every marker on this panel is a different part of that conversation. Most standard lab work catches the last word in the sentence and misses everything that came before it. You cannot treat what you cannot see, and you cannot see anything useful without knowing where the whole system starts.

---

References

1. Bhasin S et al. Testosterone Therapy in Men With Hypogonadism. JCEM. 2018 — Endocrine Society guideline: diagnosis requires two fasting morning total T measurements, distinguish primary vs secondary via LH/FSH
2. Mulhall JP et al. Evaluation and Management of Testosterone Deficiency. AUA Guideline. J Urology. 2018 — Total T below 300 ng/dL threshold, recommend LH in all men with low T
3. Travison TG et al. Harmonized Reference Ranges for Circulating Testosterone Levels. JCEM. 2017 — 9,054 men, harmonized range 264-916 ng/dL
4. Ory J et al. Secondary Polycythemia in Men Receiving Testosterone Therapy. J Urology. 2022 — Hematocrit >=52% on TRT = 35% higher MACE/VTE risk (OR 1.35)
5. Rosner W et al. Toward Excellence in Testosterone Testing. JCEM. 2013 — Sensitive LC-MS/MS required for accurate male estradiol

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness